ENO1 and Patent ductus arteriosus: Notably, the antibody response to ENO1 increased in patients who received two cycles of chemotherapy,15 highlighting the possibility that the ENO1 vaccine may boost the anti‐tumoural response of those PDA patients who cannot be surgically resected and receive chemotherapy alone.